SCHEDULE 13G/A

Maze Therapeutics Inc

Common Stock, par value $0.001 · CUSIP: 578784100

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Foresite Capital Fund IV, L.P.

  Shares: 522,657.00 · Class: 1.2%

• Foresite Capital Management IV, LLC

  Shares: 522,657.00 · Class: 1.2%

• Foresite Capital Fund V, L.P.

  Shares: 86,291.00 · Class: 0.2%

• Foresite Capital Management V, LLC

  Shares: 86,291.00 · Class: 0.2%

• James Tananbaum

  Shares: 608,948.00 · Class: 1.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.